Bio-Works Technologies AB (BIOWKS) - Total Liabilities

Latest as of December 2025: Skr21.55 Million SEK ≈ $2.32 Million USD

Based on the latest financial reports, Bio-Works Technologies AB (BIOWKS) has total liabilities worth Skr21.55 Million SEK (≈ $2.32 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See working capital position of Bio-Works Technologies AB to evaluate short-term liquidity relative to the company's equity base.

Bio-Works Technologies AB - Total Liabilities Trend (2015–2025)

This chart illustrates how Bio-Works Technologies AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Bio-Works Technologies AB balance sheet assets.

Bio-Works Technologies AB Competitors by Total Liabilities

The table below lists competitors of Bio-Works Technologies AB ranked by their total liabilities.

Company	Country	Total Liabilities
TPC Consolidated Ltd AU:TPC	Australia	AU$39.31 Million
Inspirisys Solutions Limited NSE:INSPIRISYS	India	Rs2.59 Billion
Piolink Inc KQ:170790	Korea	₩15.06 Billion
Sunnic Technology & Merchandise TWO:3360	Taiwan	NT$1.85 Billion
Harrisons Malayalam Limited NSE:HARRMALAYA	India	Rs3.37 Billion
Global SM Tech Limited KQ:900070	Korea	₩35.90 Billion
WM Technology Inc NASDAQ:MAPS	USA	$57.55 Million
Ittifak Holding A.S. IS:LRSHO	Turkey	TL9.13 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Bio-Works Technologies AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Bio-Works Technologies AB to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.20	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bio-Works Technologies AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bio-Works Technologies AB (2015–2025)

The table below shows the annual total liabilities of Bio-Works Technologies AB from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr21.55 Million ≈ $2.32 Million	+172.34%
2024-12-31	Skr7.91 Million ≈ $851.57K	-56.33%
2023-12-31	Skr18.12 Million ≈ $1.95 Million	-24.25%
2022-12-31	Skr23.92 Million ≈ $2.57 Million	+93.65%
2021-12-31	Skr12.35 Million ≈ $1.33 Million	+53.57%
2020-12-31	Skr8.04 Million ≈ $865.66K	+36.48%
2019-12-31	Skr5.89 Million ≈ $634.29K	+2.26%
2018-12-31	Skr5.76 Million ≈ $620.30K	-3.76%
2017-12-31	Skr5.99 Million ≈ $644.51K	+35.01%
2016-12-31	Skr4.44 Million ≈ $477.38K	+92.79%
2015-12-31	Skr2.30 Million ≈ $247.62K	--

About Bio-Works Technologies AB

ST:BIOWKS Sweden Medical Instruments & Supplies

Market Cap

$35.62 Million

Skr331.04 Million SEK

Market Cap Rank

#23275 Global

#440 in Sweden

Share Price

Skr3.31

Change (1 day)

-0.90%

52-Week Range

Skr2.21 - Skr4.68

All Time High

Skr28.60